Common Drug Combo Found to Cut Skin Cancer Odds
A two-ointment combo used to clear crusty skin growths known as actinic keratosis also has been found to greatly reduce the odds for squamous cell carcinomas (SCCs), the second most common form of skin cancer. (Source: WebMD Health)
Source: WebMD Health - March 22, 2019 Category: Consumer Health News Source Type: news

' Optimistic' Longer-term Outcomes for Metastatic Melanoma'Optimistic' Longer-term Outcomes for Metastatic Melanoma
Targeted therapy and immunotherapy are showing promising longer-term outcomes in metastatic melanoma. Dr Weber reviews two new studies.Medscape Oncology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 21, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology Commentary Source Type: news

Topical immunotherapy keeps skin cancer risk at bay
(Washington University School of Medicine) A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin. The study, from Washington University School of Medicine in St. Louis, Massachusetts General Hospital, and Harvard Medical School, appears March 21 in JCI Insight. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news

Immunotherapy of precancerous skin lesions may prevent squamous cell carcinoma
(Massachusetts General Hospital) A treatment previously shown to clear the precancerous skin lesions called actinic keratosis now appears to reduce the chance that the treated skin will develop squamous cell carcinomas, the second most common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2019 Category: Cancer & Oncology Source Type: news

No Elevated Cancer Risk for RA Patients With Tocilizumab (CME/CE)
(MedPage Today) -- Combined risk for new cancers except non-melanoma skin cancer with IL-6r inhibitor not significantly different than with TNF inhibitors (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Drinking Very Hot Tea Almost Doubles Risk Of Cancer, New Study Says
This study, published Wednesday in the International Journal of Cancer, was the first to pinpoint a specific temperature, according to the authors. Esophageal cancer is the eighth most common cancer in the world and is often fatal, killing approximately 400,000 people every year, according to the International Agency for Research on Cancer. It is usually caused by repeated injury to the esophagus due to smoke, alcohol, acid reflux and — maybe — hot liquids. The esophagus is a long tube through which swallowed food and liquids travel to reach the stomach. The American Cancer Society estimates that 13,750 new cas...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 20, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News tea Source Type: news

FDA Busts J & amp;J and Sientra Over Breast Implant Compliance
FDA busted two manufacturers of silicone gel-filled breast implants this week for failure to comply with post-approval study requirements. The agency sent warning letters to Irvine, CA-based Mentor Worldwide, a unit of Johnson & Johnson, and to Santa Barbara, CA-based Sientra for deficiencies in each company's post-approval study for silicone breast implant approvals. Breast implants have been a source of contention between patient advocacy groups, industry, and FDA for decades. Implants were banned from the U.S. market from 1992 to 2006, and the devices have been the cause of an ove...
Source: MDDI - March 20, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Direct targeting of G{alpha}q and G{alpha}11 oncoproteins in cancer cells
Somatic gain-of-function mutations of GNAQ and GNA11, which encode α subunits of heterotrimeric Gαq/11 proteins, occur in about 85% of cases of uveal melanoma (UM), the most common cancer of the adult eye. Molecular therapies to directly target these oncoproteins are lacking, and current treatment options rely on radiation, surgery, or inhibition of effector molecules downstream of these G proteins. A hallmark feature of oncogenic Gαq/11 proteins is their reduced intrinsic rate of hydrolysis of guanosine triphosphate (GTP), which results in their accumulation in the GTP-bound, active state. Here, we repor...
Source: Signal Transduction Knowledge Environment - March 19, 2019 Category: Science Authors: Annala, S., Feng, X., Shridhar, N., Eryilmaz, F., Patt, J., Yang, J., Pfeil, E. M., Cervantes-Villagrana, R. D., Inoue, A., Häberlein, F., Slodczyk, T., Reher, R., Kehraus, S., Monteleone, S., Schrage, R., Heycke, N., Rick, U., Engel, S., Pfeifer, Tags: STKE Research Articles Source Type: news

Misdiagnosed Malignant Tumor on an Ischemic Limb Misdiagnosed Malignant Tumor on an Ischemic Limb
Read about this case in which acral lentiginous melanoma was initially diagnosed as a vascular ulcer.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2019 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Fewer T1 Melanoma Nodal Biopsies After 2009 Staging Manual Fewer T1 Melanoma Nodal Biopsies After 2009 Staging Manual
The overall number of T1 melanomas undergoing nodal biopsy have decreased following the 7th edition of the AJCC Cancer Staging Manual (AJCC 7), according to a new study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 17, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Medical News Today: Laser probe detects deadly melanoma in seconds
A Ph.D. student has designed a cost-effective and easy-to-use device that can quickly detect cancerous skin cells. Catching cancer earlier can save lives. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 16, 2019 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Skin cancer signs: Seven symptoms of the potentially deadly disease revealed by a doctor
SKIN cancer is caused by ultraviolet light damaging the DNA in skin cells. What ’s commonly not known is there are two types of skin cancer - melanoma skin cancer and non-melanoma skin cancer. A doctor has revealed seven symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - March 15, 2019 Category: Consumer Health News Source Type: news

Dermatology practice expanding, again
The company is building a 6,000-square-foot center on Spindrift Drive in Amherst as a Mohs surgery specialty clinic focused on skin cancer procedures. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 15, 2019 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

2 new PET tracers may best FDG in cancer imaging
Cancer detection could receive a boost from two new radiotracers that have...Read more on AuntMinnie.comRelated Reading: Later PET/CT follow-up helps for oropharyngeal cancer Ga-68 PSMA-11 PET/MRI improves prostate cancer detection New PET tracer could aid melanoma detection FDG-PET/CT fails for peripheral T-cell lymphoma outcomes PET/CT predicts success of rad therapy for spinal mets (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2019 Category: Radiology Source Type: news

Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma
Patients with cutaneous squamous-cell cancer of the head and neck who have disease recurrence after definitive treatment with surgery and postoperative radiotherapy have poor survival, according to a retrospective study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 14, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Medical News Today: Marine bacteria offer new weapon against melanoma
Melanoma is notoriously difficult to treat. Recently, scientists have looked to marine bacteria to find novel ways of attacking this type of skin cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 14, 2019 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Singapore firm, Stanford team up on AI for liver cancer
Genomic medicine company Lucence Diagnostics has launched a joint effort with...Read more on AuntMinnie.comRelated Reading: Stanford launches huge dataset of chest x-rays for AI New PET tracer could aid melanoma detection AI could bring ultralow-dose imaging to amyloid PET AI may help in fight against gadolinium deposition Machine learning can predict stroke treatment outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2019 Category: Radiology Source Type: news

Evidence on Nicotinamide for High-Risk Non-Melanoma Skin Cancers
A review published in  Experimental Dermatology examined the safety and efficacy of nicotinamide in reducing non-melanoma skin cancers. (Source: CancerNetwork)
Source: CancerNetwork - March 12, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Childhood Cancer Survivors at High Risk for Skin Malignancies Childhood Cancer Survivors at High Risk for Skin Malignancies
As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing basal cell carcinoma, a Dutch study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation
MONDAY, March 11, 2019 -- As distant metastasis (DM) in head and neck squamous cell carcinoma (HNSCC) is a rare event, computed tomography of the chest may be more cost-effective for evaluation, according to a study recently published in Oral... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2019 Category: Pharmaceuticals Source Type: news

Later PET/CT follow-up helps for oropharyngeal cancer
Using PET/CT for follow-up at a later interval than what's recommended by existing...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT aids in melanoma treatment assessment CT lung screening can catch recurring head, neck cancer ASTRO: Blood test confirms HPV-related cancer remission FDG-PET/CT fails for peripheral T-cell lymphoma outcomes FDG-PET/CT helps stage men with breast cancer, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news

Study Compares Impact of Two Therapies on Survival in Squamous Cell Carcinoma
Survival rates in patients with cSCC receiving  high-dose chemoradiotherapy vs conventional radical surgery were compared. (Source: CancerNetwork)
Source: CancerNetwork - March 11, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Childhood cancer survivors at high risk for skin malignancies
(Reuters Health) - As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing common skin malignancies known as basal cell carcinoma, a Dutch study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDG-PET/CT aids in melanoma treatment assessment
Researchers have developed a new FDG-PET/CT-based approach to better monitor...Read more on AuntMinnie.comRelated Reading: New PET tracer could aid melanoma detection FDG-PET/CT fails for peripheral T-cell lymphoma outcomes PET/CT predicts success of rad therapy for spinal mets FDG-PET/CT helps stage men with breast cancer, too PET/CT makes case for directing cervical cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 7, 2019 Category: Radiology Source Type: news

A New Dosing Regimen for Nivolumab Plus Ipilimumab in Advanced Melanoma
The  CheckMate 511 phase IIIb/IV trial investigated raising the nivolumab dose to 3 mg/kg and lowering the ipilimumab dose to 1 mg/kg. (Source: CancerNetwork)
Source: CancerNetwork - March 7, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

Labour MP Chris Bryant fights through tears while discussing his cancer battle on live TV
Chris Bryant, the MP for Rhondda in Wales, revealed on Sky News today he felt 'cold' and convinced he would die when told he had stage three melanoma skin cancer on his scalp. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2019 Category: Consumer Health News Source Type: news

Seawater bacteria provides leads to fight melanoma
(American Chemical Society) Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2019 Category: International Medicine & Public Health Source Type: news

Low-cost 'cancer probe' could spot deadly melanoma early
(University of British Columbia) Work is being done at UBC on a tool to help in the early detection of melanoma: a simple, compact laser probe that can distinguish between harmless moles and cancerous ones -- in a matter of seconds. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 6, 2019 Category: Biology Source Type: news

Early Response to PD-1 Blockade Predicts Melanoma Outcomes Early Response to PD-1 Blockade Predicts Melanoma Outcomes
The response to a single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in patients with stage III/IV resectable melanoma, researchers report.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 5, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
(Society of Nuclear Medicine and Molecular Imaging) Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this way, a patient's therapy can be more effectively tailored to his or her personal response. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 5, 2019 Category: Cancer & Oncology Source Type: news

Diet Could Influence Immunotherapy Response Via Microbiome Diet Could Influence Immunotherapy Response Via Microbiome
In melanoma patients, diet may influence the response to immunotherapy with checkpoint inhibitors via an action on a patient's gut microbiome.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 4, 2019 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Genomic testing of a single patient reveals a gene commonly mutated in pediatric melanoma
(St. Jude Children's Research Hospital) Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma. The St. Jude Children's Research Hospital study appears as an advance online publication today in the journal Nature Medicine.Further research found that 33 percent of young people with spitzoid melanoma screened in this study carried novel mutations, including rearrangements, in the same gene, MAP3K8. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 4, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: New compound could fight off aggressive melanoma
New research examines the genetic chain reaction that causes a particularly aggressive form of melanoma and finds a way to stop it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 1, 2019 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer
Medical Laser Pioneer and Veteran Entrepreneur Brings Over 30 Years of Experience to Company BOCA RATON, Fla., Feb. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in h... Devices, Oncology, Dermatology, Personnel Sensus Healthcare, superficial radiation therapy, skin cancer, Keloids (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2019 Category: Pharmaceuticals Source Type: news

High-Fiber Diet May Help Gut 'Microbiome' Battle Melanoma
Title: High-Fiber Diet May Help Gut 'Microbiome' Battle MelanomaCategory: Health NewsCreated: 2/27/2019 12:00:00 AMLast Editorial Review: 2/28/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 28, 2019 Category: Cancer & Oncology Source Type: news

High-Fiber Diet May Help Gut 'Microbiome' Battle Melanoma
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 28, 2019 Category: Cancer & Oncology Source Type: news

High - Fiber Diet May Help Gut ‘ Microbiome ’ Battle Melanoma
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 28, 2019 Category: Cancer & Oncology Tags: Nursing, Oncology, Pharmacy, Alternative Medicine, Nutrition, News, Source Type: news

Neoadjuvant Anti-PD-1 Predicts Melanoma Outcomes
(MedPage Today) -- One-dose immune response tied to 63% DFS and 93% OS at 2 years (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - February 27, 2019 Category: Dermatology Source Type: news

High-Fiber Diet May Help Your Gut Battle Melanoma
New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. (Source: WebMD Health)
Source: WebMD Health - February 27, 2019 Category: Consumer Health News Source Type: news

High-Fiber Diet May Help Gut'Microbiome' Battle Melanoma
WEDNESDAY, Feb. 27, 2019 -- A healthy diet may trigger a better response to a certain kind of melanoma treatment. How? New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 27, 2019 Category: General Medicine Source Type: news

Single Dose of Keytruda May Help Put Melanoma Into Remission
Title: Single Dose of Keytruda May Help Put Melanoma Into RemissionCategory: Health NewsCreated: 2/26/2019 12:00:00 AMLast Editorial Review: 2/27/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 27, 2019 Category: Cancer & Oncology Source Type: news

Research suggests that medications for kidney transplants increase risk of skin cancer
(RCSI) A study led by researchers at RCSI (Royal College of Surgeons in Ireland) has analysed the pattern of skin cancer rates in kidney transplant patients, which suggests the increased risk is related to the anti-rejection medications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 27, 2019 Category: International Medicine & Public Health Source Type: news

Mayo Clinic Minute: 3 things you might not know about sunscreen
Most people know that slathering on the sunscreen before heading outside decreases your risk of sun damage and skin cancer. Dr. Dawn Davis, a Mayo Clinic dermatologist, says there are three other things many people don't know about sunscreen. Watch: The Mayo Clinic Minute https://youtu.be/LvswKsygobE Journalists: Broadcast-quality video pkg (0:59) is in the downloads?at the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 27, 2019 Category: Databases & Libraries Source Type: news

Keytruda May Help Put Melanoma Into Remission
Keytruda is the drug responsible for the remission of former President Jimmy Carter's cancer in 2015. Carter, then 90, had melanoma that spread to his brain and liver. Treatment with Keytruda appears to have cured him. (Source: WebMD Health)
Source: WebMD Health - February 26, 2019 Category: Consumer Health News Source Type: news

Single Dose of Keytruda May Help Put Melanoma Into Remission
TUESDAY, Feb. 26, 2019 -- For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study. Keytruda (pembrolizumab) is a PD-1 inhibitor, an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 26, 2019 Category: General Medicine Source Type: news

Smokers May Fare Worse Against the Deadliest Skin Cancer
Title: Smokers May Fare Worse Against the Deadliest Skin CancerCategory: Health NewsCreated: 2/25/2019 12:00:00 AMLast Editorial Review: 2/26/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 26, 2019 Category: Cancer & Oncology Source Type: news

Artificial intelligence could predict spread of melanoma
(American Associates, Ben-Gurion University of the Negev) The BGU/ UTSW group demonstrated that their representation of the functional state of individual cells can predict the likelihood that a stage III melanoma, with malignancies limited to the lymphatic system, will progress to stage IV, in which the cancer has spread from the principal area to the rest of the patient's body. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 26, 2019 Category: International Medicine & Public Health Source Type: news

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news

Smokers May Fare Worse Against the Deadliest Skin Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news

Single Dose of Keytruda May Help Put Melanoma Into Remission
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news